This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Products
  • Therapy Area
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Jaydess Banner

Jaydess®▼

(13.5mg intrauterine delivery system Levonorgestrel)

Jaydess Packshot

Jaydess® (13.5 mg intrauterine delivery system levonorgestrel) is an IUS indicated for contraception use for up to 3 years.

Jaydess® (13.5mg intrauterine delivery system levonorgestrel) is a low daily hormone dose delivering an average of 8 μg per day over the first year and averaging 6 μg per day over 3 years. Jaydess® provides highly effective contraception with a 3-year Pearl Index of 0.33.

Jaydess® therapeutic indications:

  • Contraception for up to 3 years.​

Jaydess® Summary of Product Characteristics (SmPC):

Summary of Product Characteristics

Related Topics:

Kyleena Content Card
Kyleena® (19.5mg Levonorgestrel)
Discover information about Kyleena's intended usage.
PP-KYL-IE-0252-1, January 2026
Mirena Product Content Card
Mirena® (52mg levonorgestrel) Intrauterine System
Learn more about Mirena®.
PP-MIR-IE-0069-1, January 2026
Qlaira Content Card
Qlaira® (Estradiol valerate/dienogest)
Discover more about intended use of Qlaira®
PP-QLA-IE-0001-1, January 2026

PP-JAY-IE-0056-1   |   January 2026

 

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professional are asked to report any suspected adverse reactions.

    • 1
      Jaydess®▼13.5 mg intrauterine delivery system (levonorgestrel): Summary of Product Characteristics.